In this Article, the Authors neglected to include the Data and Material Availability section. This section should read:
“Data and material availability
The novel mouse strain generated in this study is available on request from Chugai Pharmaceutical Co., Ltd. (Chugai) under an MTA between the institution and Chugai. The following restrictions, in principle, apply to this mouse strain:
1. Cross-breeding the mouse strain with other mouse strains is prohibited.
2. Additional gene manipulations to the mouse strain are prohibited.
3. Use of the mouse strain for commercial purposes is prohibited.
4. Further transfer of the mouse strain to third parties is prohibited.
Our license agreement with GeneBridges restricts distribution of the BAC vectors, which were constructed using their Red/ET system.”
Additional information
The online version of the original article can be found at https://doi.org/10.1038/srep45839
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Ueda, O., Wada, N., Kinoshita, Y. et al. Correction: Corrigendum: Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3–mediated therapeutics. Sci Rep 8, 46960 (2018). https://doi.org/10.1038/srep46960
Published:
DOI: https://doi.org/10.1038/srep46960
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
